Model Number: QQM68-#2017 Brand Name: QQM Key Specifications/Special Features: ABT-199 (GDC-0199) is Bcl-2-selective inhibitor with Ki of <0.01 nM, >4800-fold more selective versus Bcl-xL and Bcl-w and no activity to Mcl-1IC50 value: <0.01nm (Ki)Target: Bcl-2 selectiveABT-199 is potent and selective inhibitor of B-cell lymphoma-2 (BCL-2) family proteins, currently in clinical trials ABT-199 inhibits the growth of BCL-2-dependent tumors in vivo and spares human plateletsSingle dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 hThese data indicate that selective pharmacological inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematological cancers4-CEC,4CLPVP,BK-EBDP,APPP,MDPHP,5FADB,ADB-F,5F-MN24,FUB-AMB,MMB-FUBINACA,2-NMC,MDPT,4-CDC,4-EMC,4CL-PET,MD-PHP,THPVP,MMBC,Dibutylone,5FSDB005,4CL-PMT,4F-MPH,4MPD,FMXP,BMDP,4CPRC,HEX-EN4FPHPMDMB-2201,5FMDMB-2201,Furanylfentanyl,GEFITINIB,IBRUTINIB, ERLOTINIB, 2-A1MP,U-47700, U49900, Mexedrone, Etizolam, 3FPM, Isopropylphenidate, 4FIBF